|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2003-8-28
|
|
pubmed:abstractText |
To evaluate serum matrix metalloproteinase 3 (MMP-3) levels in comparison to C-reactive protein (CRP) in periods with and without progression of radiological damage in patients with early rheumatoid arthritis (RA).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0392-856X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
21
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
465-72
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:12942698-Adult,
pubmed-meshheading:12942698-Aged,
pubmed-meshheading:12942698-Arthritis, Rheumatoid,
pubmed-meshheading:12942698-Biological Markers,
pubmed-meshheading:12942698-C-Reactive Protein,
pubmed-meshheading:12942698-Disease Progression,
pubmed-meshheading:12942698-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:12942698-Female,
pubmed-meshheading:12942698-Humans,
pubmed-meshheading:12942698-Male,
pubmed-meshheading:12942698-Matrix Metalloproteinase 3,
pubmed-meshheading:12942698-Middle Aged,
pubmed-meshheading:12942698-Observer Variation,
pubmed-meshheading:12942698-Probability,
pubmed-meshheading:12942698-Prospective Studies,
pubmed-meshheading:12942698-Reference Values,
pubmed-meshheading:12942698-Sampling Studies,
pubmed-meshheading:12942698-Sensitivity and Specificity,
pubmed-meshheading:12942698-Severity of Illness Index,
pubmed-meshheading:12942698-Time Factors
|
|
pubmed:articleTitle |
Serum matrix metalloproteinase 3 levels in comparison to C-reactive protein in periods with and without progression of radiological damage in patients with early rheumatoid arthritis.
|
|
pubmed:affiliation |
Department of Rheumatology, University Hospital Groningen, The Netherlands. m.d.posthumus@int.azg.nl
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|
